Rengo Co (3941) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
9 Jul, 2026Executive summary
Net sales for Apr–Dec 2024 rose 7.2% year-over-year to ¥741.5 billion, driven by subsidiary additions and product price revisions.
Operating profit declined 22% year-over-year to ¥33.4 billion, and profit attributable to owners of parent dropped 20.1% to ¥26.4 billion, mainly due to higher raw material and fixed costs.
Extraordinary gains included a gain on bargain purchase, while losses were driven by plant renewal and disaster-related expenses.
Comprehensive income decreased 41.9% year-over-year to ¥33,807 million.
Financial highlights
Operating profit fell by ¥9.3 billion year-over-year, mainly due to higher OCC costs, unfavorable product mix, and increased fixed costs.
Total assets increased by ¥81.8 billion to ¥1,254.3 billion as of Dec 31, 2024.
Shareholders' equity ratio decreased to 35.9%.
EBITDA for FY2024 is forecast at ¥94.5 billion, down from ¥101.1 billion in FY2023.
Basic earnings per share declined to ¥106.34 from ¥133.15 year-over-year.
Outlook and guidance
FY2024 net sales forecast remains at ¥1,000.0 billion, but operating profit guidance was revised down to ¥38.0 billion (from ¥50.0 billion).
Profit attributable to owners of parent is projected at ¥28.0 billion, down from the previous forecast of ¥35.0 billion.
Capital expenditures are expected to rise to ¥101.5 billion, a 37.5% increase year-over-year.
Assumptions include a stronger yen and lower crude oil prices compared to prior forecasts.
Latest events from Rengo Co
- Strategic investments, price revisions, and sustainability initiatives drive growth and efficiency.3941
Investor presentation9 Jul 2026 - Vision120 drives sustainable growth, ESG innovation, and global expansion toward FY3/2030 targets.3941
Investor presentation9 Jul 2026 - Vision120 drives growth, sustainability, and global expansion, with stable financial performance.3941
Investor presentation9 Jul 2026 - Vision120 targets higher ROE and shareholder value via disciplined capital allocation and stable returns.3941
Investor presentation9 Jul 2026 - Profit attributable to owners jumped 45.5% on extraordinary and acquisition gains.3941
Q1 20259 Jul 2026 - Net sales rose 9.3% year-over-year, but operating profit declined 22.9% due to higher costs.3941
Q2 20259 Jul 2026 - Sales rose but profits declined on higher costs; modest growth and stable dividends forecasted.3941
Q4 20259 Jul 2026 - Operating profit rose modestly, but net income fell sharply; flexible packaging outperformed.3941
Q2 20269 Jul 2026 - Revenue up 2.0% year-over-year, but profits fell sharply on higher costs and currency impacts.3941
Q1 20269 Jul 2026